LONDON, March 28, 2014 /PRNewswire/ --
On Wednesday, March 26, 2014, the NASDAQ Composite finished at 4,173.58, down 1.43%, the Dow Jones Industrial Average fell by 0.60% to close the session at 16,268.99, and the S&P 500 ended the day at 1,852.56, down 0.70%. The losses were broad based with nine out of ten sectors ending the session in negative. The S&P 500 Health Care Sector Index finished the day at 672.05, up 0.05%, and the same has gained 4.63% in the last three months. Investor-Edge has initiated coverage on the following equities: Laboratory Corp. of America Holdings (NYSE: LH), Omnicare Inc. (NYSE: OCR), DaVita HealthCare Partners Inc. (NYSE: DVA), and MEDNAX Inc. (NYSE: MD). Free technical research on LH, OCR, DVA, and MD can be downloaded upon signing up at:
http://www.investor-edge.com/533-register
Shares in Laboratory Corp. of America Holdings recorded a trading volume of 4.22 million shares, as compared with a three months average volume of 1.03 million shares. The stock ended the day at $98.64, up 4.15% after vacillating between $97.50 and $102.00. The company's stock traded at a PE ratio of 15.42. Shares in Laboratory Corp. of America Holdings have gained 1.66% in the previous three trading sessions, 6.01% in the last one month and 7.96% on YTD basis. The company's stock is trading above its 50-day and 200-day moving averages of $92.59 and $96.98, respectively. Furthermore, the stock is trading at a Relative Strength Index (RSI) of 50.40. Sign up today to read free research on LH at:
http://www.investor-edge.com/533-LH-27Mar2014.pdf
On Wednesday, shares in Omnicare Inc. edged 0.22% lower to close the session at $59.40. A total of 1.12 million shares were traded, which is below the three months average volume of 1.30 million. The stock oscillated between $59.30 and $60.16 during the session. The stock traded at a PE ratio of 22.11. Omnicare Inc.'s shares have advanced 0.93% in the previous three trading sessions, but they have declined 0.39% in the last one month and 1.59% on YTD basis. The stock is trading below its 50-day moving average. Omnicare Inc.'s 50-day moving average of $60.67 is above its 200-day moving average of $56.25. Additionally, shares of the company are trading at an RSI of 52.16. Sign up today to read free research on OCR at:
http://www.investor-edge.com/533-OCR-27Mar2014.pdf
Shares in DaVita HealthCare Partners Inc. finished the session 0.42% higher at $68.90. The stock recorded trading volume of 2.13 million shares as compared to a three months average volume of 1.46 million shares. The stock fluctuated between $68.88 and $70.03 during the session. Shares of the company traded at a PE ratio of 16.87. DaVita HealthCare Partners Inc.'s stock has advanced 2.07% in the last one month and 8.73% on YTD basis, while the same has fallen by 1.30% in the previous three trading sessions. The stock is trading above its 50-day and 200-day moving averages of $66.46 and $60.72, respectively. Moreover, the stock is trading at an RSI of 55.76. Sign up today to read free research on DVA at:
http://www.investor-edge.com/533-DVA-27Mar2014.pdf
MEDNAX Inc.'s stock reported a trading volume of 0.50 million shares, as compared with a three months average volume of 0.56 million shares. The stock ended the day at $62.77, down 0.68% and at an intraday range of $62.65 and $63.73. Shares of the company traded at a PE ratio of 22.62. MEDNAX Inc.'s shares have gained 0.08% in the previous three trading sessions, 4.01% in the last month and 17.59% on YTD basis. The stock is trading above its 50-day and 200-day moving averages of $58.53 and $52.69, respectively. Furthermore, the stock is trading at an RSI of 67.94. Sign up today to read free research on MD at:
http://www.investor-edge.com/533-MD-27Mar2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Investor-Edge.com
SOURCE Investor-Edge
